Connection

RU CHEN to Biomarkers, Tumor

This is a "connection" page, showing publications RU CHEN has written about Biomarkers, Tumor.
Connection Strength

1.285
  1. Proteome alterations in pancreatic ductal adenocarcinoma. Cancer Lett. 2020 01 28; 469:429-436.
    View in: PubMed
    Score: 0.187
  2. Glycoproteins and glycoproteomics in pancreatic cancer. World J Gastroenterol. 2016 Nov 14; 22(42):9288-9299.
    View in: PubMed
    Score: 0.152
  3. Biomarkers for colitis-associated colorectal cancer. World J Gastroenterol. 2016 Sep 21; 22(35):7882-91.
    View in: PubMed
    Score: 0.151
  4. Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics. J Proteome Res. 2011 Jan 07; 10(1):200-9.
    View in: PubMed
    Score: 0.100
  5. Pilot study of blood biomarker candidates for detection of pancreatic cancer. Pancreas. 2010 Oct; 39(7):981-8.
    View in: PubMed
    Score: 0.100
  6. Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia. Mol Cancer. 2010 Jun 15; 9:149.
    View in: PubMed
    Score: 0.098
  7. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteomics. 2007 Aug; 6(8):1331-42.
    View in: PubMed
    Score: 0.079
  8. Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas. 2007 Jan; 34(1):70-9.
    View in: PubMed
    Score: 0.077
  9. Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics. 2005 Apr; 4(4):523-33.
    View in: PubMed
    Score: 0.067
  10. Proteomic Investigation of Glyceraldehyde-Derived Intracellular AGEs and Their Potential Influence on Pancreatic Ductal Cells. Cells. 2021 04 24; 10(5).
    View in: PubMed
    Score: 0.052
  11. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome. BMC Cancer. 2019 Jun 24; 19(1):617.
    View in: PubMed
    Score: 0.046
  12. Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer. Proteomics Clin Appl. 2017 09; 11(9-10).
    View in: PubMed
    Score: 0.040
  13. Quantitative Proteomics Based on Optimized Data-Independent Acquisition in Plasma Analysis. J Proteome Res. 2017 02 03; 16(2):665-676.
    View in: PubMed
    Score: 0.038
  14. Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. Gastroenterology. 2013 Oct; 145(4):885-894.e3.
    View in: PubMed
    Score: 0.030
  15. Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. J Proteome Res. 2012 Mar 02; 11(3):1937-48.
    View in: PubMed
    Score: 0.027
  16. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J Proteome Res. 2011 May 06; 10(5):2359-76.
    View in: PubMed
    Score: 0.026
  17. BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis. Gut. 2017 05; 66(5):852-862.
    View in: PubMed
    Score: 0.009
  18. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma. J Proteome Res. 2014 Mar 07; 13(3):1293-306.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.